Description of outcome and adverse events in 21 cats with locally advanced nasal planum squamous cell carcinoma treated with electrochemotherapy.

IF 1.9 2区 农林科学 Q2 VETERINARY SCIENCES Journal of Feline Medicine and Surgery Pub Date : 2024-07-01 DOI:10.1177/1098612X241248043
Elena Ferrer-Jorda, Ignacio Rodríguez-Pizà
{"title":"Description of outcome and adverse events in 21 cats with locally advanced nasal planum squamous cell carcinoma treated with electrochemotherapy.","authors":"Elena Ferrer-Jorda, Ignacio Rodríguez-Pizà","doi":"10.1177/1098612X241248043","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Squamous cell carcinoma (SCC) is the most common tumour in the nasal planum of cats. Surgery has traditionally been the treatment of choice but might not be feasible in locally advanced scenarios. Electrochemotherapy (ECT) has shown good control in superficial tumours, but there is a lack of robust information about efficacy in locally advanced cases. The aim of this study was to assess the safety and efficacy of ECT in the treatment of locally advanced stage nasal planum SCC in cats.</p><p><strong>Methods: </strong>The clinical database of a veterinary referral hospital was searched retrospectively for cats diagnosed with a locally advanced nasal planum SCC (T<sub>3</sub>N<sub>0</sub>M<sub>0</sub> or T<sub>4</sub>N<sub>0</sub>M<sub>0</sub>) that had received ECT. Local response, adverse events and outcome were documented. The data were evaluated by inferential statistics and correlations between response, recurrence, feline immunodeficiency virus/feline leukaemia virus status, number of treatments, voltage and severity of adverse events, with Kaplan-Meier curves and log-rank tests. Statistical significance was set at <i>P</i> <0.05.</p><p><strong>Results: </strong>In total, 21 cats were enrolled over a 4-year period. Nineteen cats achieved a complete response (CR) and two cats a partial response (PR) for an overall response rate of 100%. Cats achieving a CR had a median disease-free interval of 182 days (range 128-327) and those with a PR had a median progression-free survival of 156.5 days (range 122-191). The median time to progression was not reached. The overall survival was 453 days for a median follow-up of 341 days (range 191-989). Of the cats, 62% had grade 3 or 4 toxicities, but no deaths due to the treatment were documented. Only voltage was correlated with longer survival (<i>P</i> = 0.001).</p><p><strong>Conclusions and relevance: </strong>ECT appears to be an effective treatment for feline nasal planum SCC and could be considered a first-line therapy for locally advanced cases. Toxicities reported can be severe in the short term and these could be secondary to more invasive lesions and equipment used.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"26 7","pages":"1098612X241248043"},"PeriodicalIF":1.9000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292942/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Feline Medicine and Surgery","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1177/1098612X241248043","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Squamous cell carcinoma (SCC) is the most common tumour in the nasal planum of cats. Surgery has traditionally been the treatment of choice but might not be feasible in locally advanced scenarios. Electrochemotherapy (ECT) has shown good control in superficial tumours, but there is a lack of robust information about efficacy in locally advanced cases. The aim of this study was to assess the safety and efficacy of ECT in the treatment of locally advanced stage nasal planum SCC in cats.

Methods: The clinical database of a veterinary referral hospital was searched retrospectively for cats diagnosed with a locally advanced nasal planum SCC (T3N0M0 or T4N0M0) that had received ECT. Local response, adverse events and outcome were documented. The data were evaluated by inferential statistics and correlations between response, recurrence, feline immunodeficiency virus/feline leukaemia virus status, number of treatments, voltage and severity of adverse events, with Kaplan-Meier curves and log-rank tests. Statistical significance was set at P <0.05.

Results: In total, 21 cats were enrolled over a 4-year period. Nineteen cats achieved a complete response (CR) and two cats a partial response (PR) for an overall response rate of 100%. Cats achieving a CR had a median disease-free interval of 182 days (range 128-327) and those with a PR had a median progression-free survival of 156.5 days (range 122-191). The median time to progression was not reached. The overall survival was 453 days for a median follow-up of 341 days (range 191-989). Of the cats, 62% had grade 3 or 4 toxicities, but no deaths due to the treatment were documented. Only voltage was correlated with longer survival (P = 0.001).

Conclusions and relevance: ECT appears to be an effective treatment for feline nasal planum SCC and could be considered a first-line therapy for locally advanced cases. Toxicities reported can be severe in the short term and these could be secondary to more invasive lesions and equipment used.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
描述 21 只局部晚期鼻翼鳞状细胞癌猫接受电化学疗法治疗后的疗效和不良反应。
目的:鳞状细胞癌(SCC)是猫鼻腔最常见的肿瘤。手术是传统的首选治疗方法,但在局部晚期情况下可能并不可行。电化学疗法(ECT)对浅表肿瘤有良好的控制效果,但对局部晚期病例的疗效缺乏可靠的信息。本研究旨在评估电化学疗法治疗猫局部晚期鼻腔SCC的安全性和有效性:方法:对一家兽医转诊医院的临床数据库进行回顾性检索,寻找被诊断为鼻腔局部晚期SCC(T3N0M0或T4N0M0)并接受过ECT治疗的猫咪。记录了局部反应、不良事件和结果。数据通过推理统计和 Kaplan-Meier 曲线及对数秩检验进行评估,并对反应、复发、猫免疫缺陷病毒/猫白血病病毒状态、治疗次数、电压和不良事件严重程度之间的相关性进行分析。统计显著性以 P 为标准:共有 21 只猫在 4 年内接受了治疗。19 只猫获得了完全应答 (CR),2 只猫获得了部分应答 (PR),总应答率为 100%。获得 CR 的猫的中位无病生存期为 182 天(128-327 天不等),获得 PR 的猫的中位无进展生存期为 156.5 天(122-191 天不等)。无进展生存期的中位数没有达到。总生存期为 453 天,中位随访时间为 341 天(范围 191-989)。62%的猫出现了 3 级或 4 级毒性反应,但没有因治疗而死亡的记录。只有电压与较长的存活期相关(P = 0.001):ECT似乎是治疗猫鼻腔SCC的有效方法,可作为局部晚期病例的一线疗法。据报道,短期内的毒性可能很严重,这可能是继发性病变和所使用的设备之后出现的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.90
自引率
17.60%
发文量
254
审稿时长
8-16 weeks
期刊介绍: JFMS is an international, peer-reviewed journal aimed at both practitioners and researchers with an interest in the clinical veterinary healthcare of domestic cats. The journal is published monthly in two formats: ‘Classic’ editions containing high-quality original papers on all aspects of feline medicine and surgery, including basic research relevant to clinical practice; and dedicated ‘Clinical Practice’ editions primarily containing opinionated review articles providing state-of-the-art information for feline clinicians, along with other relevant articles such as consensus guidelines.
期刊最新文献
Doxycycline with or without famciclovir for infectious ophthalmic and respiratory disease: a prospective, randomized, masked, placebo-controlled trial in 373 kittens. Evaluation of cats treated with robenacoxib after gastrointestinal surgery. Serological and molecular detection of Toxoplasma gondii in cats in Europe with evaluation of associated risk factors for pathogen contact/infection. Nasopharyngeal stenosis in cats: a retrospective study of 21 cases comparing endoscopic and surgical treatment (2018-2022). Risk factors affecting all-cause mortality in cats hospitalized by a referral soft tissue service.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1